Protagonist Therapeutics Inc (NASDAQ:PTGX) concluded the trading at $54.90 on Thursday, March 13 with a fall of -4.77% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $57.65 and 5Y monthly beta
Protagonist Therapeutics Inc (NASDAQ:PTGX) traded at $55.95 at close of the session on Monday, March 10 and made an upward move of 45.89% on its previous day’s price. Protagonist Therapeutics Inc has a market cap of $3.43 billion and is expected to release its quarterly
Protagonist Therapeutics Inc (NASDAQ:PTGX) price on Friday, February 28, rose 3.44% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $37.59. A look at the stock’s price movement, the close in the last trading session was $36.34. The
Protagonist Therapeutics Inc (NASDAQ:PTGX) price on Friday, February 07, rose 2.99% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $38.88. A look at the stock’s price movement, the close in the last trading session was $37.75, moving
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
